Skip to main content
Toggle navigation
Search
Home
Anitocabtagene Autoleucel: Innovation in BCMA-Targeting Therapeutics
Saturday, September 20, 2025
10:25 - 10:33
East Coast USA Time
Location: Hall FG
Speaker(s)
AK
Ana Kostic, MD (she/her/hers)
Vice President Clinical Development
Arcellx, Inc.
Seattle, Washington